Kiernan Jane E 4

What Happened
Jane E. Kiernan, a director of Treace Medical Concepts, Inc. (TMCI), was granted 30,000 restricted stock units (RSUs) on May 19, 2026. The grant is reported as an award (code A) at $0.00 per share (no cash exchanged). The RSUs represent the right to receive one share of TMCI common stock per RSU upon vesting.

Key Details

• Transaction date and type: 2026-05-19 — Grant/Award (A) of 30,000 RSUs at $0.00 per share.
• Reported value: $0 cash consideration for the award (economic value depends on future share price at settlement).
• Vesting: RSUs vest 100% on the earlier of (a) May 19, 2027 or (b) the date of the 2027 annual meeting, subject to continued service (see footnote).
• Deferral: Reporting person voluntarily elected to defer receipt of the underlying shares until a change in control or the reporting person’s separation of service.
• Shares owned after transaction: Not specified in this filing.
• Filing timeliness: Form 4 filed with a period and report date of 2026-05-19, indicating a timely report for that transaction.

Context
RSUs are a form of compensation that convert to shares upon vesting; this award is neither a cash purchase nor a sale and does not by itself indicate insider buying or selling intent. The deferral election means Kiernan may not receive the shares until a later triggering event (change in control or separation), delaying any immediate market impact.